US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Biofrontera Inc

0.9300

+0.100012.05%

Post-market: 0.9061-0.0239-2.57%18:26 EST

Volume:525.89K

Turnover:472.53K

Market Cap:10.83M

PE:-0.50

High:0.9492

Open:0.8400

Low:0.8201

Close:0.8300

52wk High:1.19

52wk Low:0.5360

Shares:11.65M

Float Shares:9.11M

Volume Ratio:1.85

T/O Rate:5.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8444

EPS(LYR):-3.2193

ROE:-1191.73%

ROA:-64.91%

PB:-4.20

PE(LYR):-0.29

Loading ...

Overview Company News Filings

Biofrontera Locks Phase 1 PK Study Database for Ameluz in Actinic Keratoses Expansion

Biofrontera Inc - Supplemental Nda Submission for Extremities, Neck and Trunk Indication Expected in Q3 2026

THOMSON REUTERS

Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Keratoses on Trunk and Extremities

THOMSON REUTERS

Biofrontera Raises 2025 EBITDA Outlook While Keeping Revenue Target

FDA Accepts Biofrontera sNDA Filing for Ameluz PDT in Superficial Basal Cell Carcinoma

Biofrontera Inc - FDA Sets Pdufa Date for September 28, 2026

THOMSON REUTERS

Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® Pdt in Superficial Basal Cell Carcinoma

THOMSON REUTERS

BRIEF-Biofrontera Announces Positive Results In Phase 3 Study Of Ameluz® Pdt

Biofrontera Reports Positive Phase 3 Results for Ameluz PDT in Treating Actinic Keratoses Beyond Face and Scalp

Biofrontera Inc - to Submit Snda to FDA in Q3 2026

THOMSON REUTERS

Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® Pdt for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint

THOMSON REUTERS

Biofrontera Inc - Ameluz Pdt Achieves 45.6% Clearance Rate in Phase 3 Study

THOMSON REUTERS

Biofrontera Inc - Primary Endpoint Achieved With Complete Clearance Rate of Ak Lesions

THOMSON REUTERS

Biofrontera Inc - Ak Lesion Clearance 73.1% in Fas and 80.3% in PPS

THOMSON REUTERS

There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise

Simply Wall St.

Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues Between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth

THOMSON REUTERS

Biofrontera Inc. Projects 2025 Revenue Growth of Up to 13%

BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory Milestones

Biofrontera Inc. Locks Databases for Key Ameluz PDT Clinical Trials in Actinic Keratosis and Acne Vulgaris

Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BFRI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BFRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BFRI\",,,,,undefined,":{"symbol":"BFRI","market":"US","secType":"STK","nameCN":"Biofrontera Inc","latestPrice":0.93,"timestamp":1771448400000,"preClose":0.83,"halted":0,"volume":525885,"hourTrading":{"tag":"盘后","latestPrice":0.9061,"preClose":0.93,"latestTime":"18:26 EST","volume":9859,"amount":9114.0795934,"timestamp":1771457160209,"change":-0.0239,"changeRate":-0.025699,"amplitude":0.031075},"delay":0,"changeRate":0.12048192771084348,"floatShares":9105100,"shares":11648323,"eps":-1.8444,"marketStatus":"Post-Mkt","change":0.1,"latestTime":"02-18 18:57:38 EST","open":0.84,"high":0.9492,"low":0.8201,"amount":472529.65449299995,"amplitude":0.155542,"askPrice":0.95,"askSize":903,"bidPrice":0.8284,"bidSize":240,"shortable":3,"etf":0,"ttmEps":-1.8444,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771462800000},"marketStatusCode":4,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":0.83,"preHourTrading":{"tag":"盘前","latestPrice":0.84,"preClose":0.83,"latestTime":"09:29 EST","volume":5181,"amount":4340.9956623,"timestamp":1771424956915,"change":0.01,"changeRate":0.012048,"amplitude":0.021446},"postHourTrading":{"tag":"盘后","latestPrice":0.9061,"preClose":0.93,"latestTime":"18:26 EST","volume":9859,"amount":9114.0795934,"timestamp":1771457160209,"change":-0.0239,"changeRate":-0.025699,"amplitude":0.031075},"volumeRatio":1.850263,"impliedVol":4.5485,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BFRI\",,,,,undefined,":{"symbol":"BFRI","floatShares":9105100,"roa":"-64.91%","roe":"-1191.73%","lyrEps":-3.219348,"volumeRatio":1.850263,"shares":11648323,"dividePrice":0,"high":0.9492,"amplitude":0.155542,"preClose":0.83,"low":0.8201,"week52Low":0.536,"pbRate":"-4.20","psRate":"0.29","week52High":1.19,"institutionHeld":0,"latestPrice":0.93,"committee":-0.580052,"eps":-1.8444,"divideRate":0,"volume":525885,"delay":0,"ttmEps":-1.8444,"open":0.84,"prevYearClose":0.57,"prevWeekClose":0.7787,"prevMonthClose":0.9303,"prevQuarterClose":0.57,"fiveDayClose":0.78,"twentyDayClose":0.8338,"sixtyDayClose":0.809},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BFRI\",params:#limit:5,,,undefined,":[{"date":"2026-01-13","symbol":"BFRI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768294800000,"name":null,"time":"Pre-Market","dateTimestamp":1768280400000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"BFRI","fiscalQuarterEnding":"2025/09","expectedEps":-0.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2025-08-13","symbol":"BFRI","fiscalQuarterEnding":"2025/06","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2025-05-15","symbol":"BFRI","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-03-21","symbol":"BFRI","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742529600000,"reportTimeType":"pre","actualEps":-2.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BFRI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BFRI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1639890000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BFRI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BFRI","date":"2026-02-17","current":-0.485253,"percent":0.684659,"low":-27.116173,"twenty":-1.900906,"median":-0.657992,"eighty":-0.397444,"high":-0.066549,"avg":-2.061343,"sd":4.875768,"marketCap":9070549},"quantilePoints":[{"date":"2021-10-15","current":-6.366969,"twenty":-6.366969,"median":-6.366969,"eighty":-6.366969,"marketCap":66000000},{"date":"2021-10-21","current":-6.366969,"twenty":-6.366969,"median":-6.366969,"eighty":-6.366969,"marketCap":66000000},{"date":"2021-10-29","current":-3.403434,"twenty":-6.366969,"median":-6.366969,"eighty":-5.354042,"marketCap":35280000},{"date":"2021-11-05","current":-3.625699,"twenty":-6.366969,"median":-5.860506,"eighty":-4.229983,"marketCap":37584000},{"date":"2021-11-12","current":-3.771175,"twenty":-6.366969,"median":-4.632838,"eighty":-3.625699,"marketCap":39092000},{"date":"2021-11-19","current":-2.987845,"twenty":-6.366969,"median":-4.106888,"eighty":-3.403434,"marketCap":30972000},{"date":"2021-11-26","current":-8.84044,"twenty":-6.366969,"median":-4.106888,"eighty":-3.354891,"marketCap":91640000},{"date":"2021-12-03","current":-2.642082,"twenty":-6.366969,"median":-3.849508,"eighty":-2.984309,"marketCap":61808860},{"date":"2021-12-10","current":-3.322712,"twenty":-6.366969,"median":-3.597723,"eighty":-2.953711,"marketCap":77731517},{"date":"2021-12-17","current":-4.393157,"twenty":-6.366969,"median":-3.771175,"eighty":-2.966985,"marketCap":102773515},{"date":"2021-12-23","current":-8.148997,"twenty":-6.366969,"median":-3.983793,"eighty":-2.980772,"marketCap":190637633},{"date":"2021-12-31","current":-5.498321,"twenty":-6.366969,"median":-4.249695,"eighty":-3.014276,"marketCap":128627712},{"date":"2022-01-07","current":-3.750849,"twenty":-6.366969,"median":-4.269406,"eighty":-3.139751,"marketCap":87747362},{"date":"2022-01-14","current":-3.61924,"twenty":-6.366969,"median":-4.224944,"eighty":-3.233738,"marketCap":84668507},{"date":"2022-01-21","current":-2.537124,"twenty":-6.366969,"median":-4.076215,"eighty":-3.032863,"marketCap":59353479},{"date":"2022-01-28","current":-2.222725,"twenty":-6.156743,"median":-3.875146,"eighty":-2.952585,"marketCap":51998436},{"date":"2022-02-04","current":-3.209791,"twenty":-5.710021,"median":-3.761012,"eighty":-2.932017,"marketCap":75089848},{"date":"2022-02-11","current":-2.507878,"twenty":-5.507095,"median":-3.625699,"eighty":-2.880769,"marketCap":58669289},{"date":"2022-02-18","current":-2.142298,"twenty":-5.440609,"median":-3.536176,"eighty":-2.727944,"marketCap":50116914},{"date":"2022-02-25","current":-2.251972,"twenty":-5.354042,"median":-3.453019,"eighty":-2.632182,"marketCap":52682626},{"date":"2022-03-04","current":-1.959508,"twenty":-5.295159,"median":-3.3907,"eighty":-2.513727,"marketCap":45840727},{"date":"2022-03-11","current":-1.718225,"twenty":-5.050082,"median":-3.285586,"eighty":-2.38358,"marketCap":40196160},{"date":"2022-03-18","current":-2.156921,"twenty":-4.954188,"median":-3.211653,"eighty":-2.234424,"marketCap":50459009},{"date":"2022-03-25","current":-2.178856,"twenty":-4.721615,"median":-3.089149,"eighty":-2.215414,"marketCap":50972152},{"date":"2022-04-01","current":-2.56637,"twenty":-4.698495,"median":-2.987845,"eighty":-2.216876,"marketCap":60037668},{"date":"2022-04-08","current":-2.095403,"twenty":-4.621682,"median":-2.954079,"eighty":-2.216876,"marketCap":79023940},{"date":"2022-04-14","current":-1.904912,"twenty":-4.577059,"median":-2.947271,"eighty":-2.208102,"marketCap":71839945},{"date":"2022-04-22","current":-1.809666,"twenty":-4.393157,"median":-2.910015,"eighty":-2.164233,"marketCap":68247948},{"date":"2022-04-29","current":-1.678137,"twenty":-4.386649,"median":-2.858834,"eighty":-2.142298,"marketCap":63287571},{"date":"2022-05-06","current":-1.578356,"twenty":-4.300344,"median":-2.763924,"eighty":-2.039935,"marketCap":59524526},{"date":"2022-05-13","current":-1.655607,"twenty":-4.284596,"median":-2.676044,"eighty":-1.88677,"marketCap":47380154},{"date":"2022-05-20","current":-1.907529,"twenty":-4.269406,"median":-2.629707,"eighty":-1.841415,"marketCap":54589677},{"date":"2022-05-27","current":-1.94727,"twenty":-4.229983,"median":-2.580993,"eighty":-1.821426,"marketCap":55726962},{"date":"2022-06-03","current":-1.781685,"twenty":-4.221921,"median":-2.562715,"eighty":-1.814497,"marketCap":50988274},{"date":"2022-06-10","current":-1.516751,"twenty":-4.17222,"median":-2.507878,"eighty":-1.797227,"marketCap":43406375},{"date":"2022-06-17","current":-1.371037,"twenty":-4.025765,"median":-2.460352,"eighty":-1.75891,"marketCap":39236330},{"date":"2022-06-24","current":-1.384283,"twenty":-3.987129,"median":-2.438417,"eighty":-1.718664,"marketCap":39615425},{"date":"2022-07-01","current":-1.192206,"twenty":-3.918605,"median":-2.412827,"eighty":-1.685259,"marketCap":34118548},{"date":"2022-07-08","current":-1.178959,"twenty":-3.864891,"median":-2.354334,"eighty":-1.675378,"marketCap":33739453},{"date":"2022-07-15","current":-1.132596,"twenty":-3.818175,"median":-2.270251,"eighty":-1.649308,"marketCap":32412620},{"date":"2022-07-22","current":-1.251816,"twenty":-3.763045,"median":-2.230037,"eighty":-1.606944,"marketCap":35824475},{"date":"2022-07-29","current":-0.947141,"twenty":-3.724527,"median":-2.215414,"eighty":-1.570914,"marketCap":27105291},{"date":"2022-08-05","current":-1.000128,"twenty":-3.661307,"median":-2.178856,"eighty":-1.410636,"marketCap":28621670},{"date":"2022-08-12","current":-1.286738,"twenty":-3.623115,"median":-2.164233,"eighty":-1.384283,"marketCap":33206853},{"date":"2022-08-19","current":-1.049467,"twenty":-3.599443,"median":-2.156921,"eighty":-1.363089,"marketCap":27083604},{"date":"2022-08-26","current":-1.122474,"twenty":-3.54289,"median":-2.11885,"eighty":-1.300142,"marketCap":28967680},{"date":"2022-09-02","current":-1.085971,"twenty":-3.502605,"median":-2.069182,"eighty":-1.254466,"marketCap":28025642},{"date":"2022-09-09","current":-1.140725,"twenty":-3.482771,"median":-2.003377,"eighty":-1.226648,"marketCap":29438700},{"date":"2022-09-16","current":-0.985587,"twenty":-3.403377,"median":-1.927399,"eighty":-1.212407,"marketCap":25435036},{"date":"2022-09-23","current":-0.842312,"twenty":-3.40066,"median":-1.904912,"eighty":-1.178959,"marketCap":21737536},{"date":"2022-09-30","current":-0.958209,"twenty":-3.388152,"median":-1.893838,"eighty":-1.150374,"marketCap":24728508},{"date":"2022-10-07","current":-1.031216,"twenty":-3.366909,"median":-1.87908,"eighty":-1.122474,"marketCap":26612584},{"date":"2022-10-14","current":-1.104222,"twenty":-3.307862,"median":-1.818114,"eighty":-1.104222,"marketCap":28496661},{"date":"2022-10-21","current":-1.095096,"twenty":-3.246576,"median":-1.813276,"eighty":-1.104222,"marketCap":28261152},{"date":"2022-10-28","current":-0.976461,"twenty":-3.23356,"median":-1.804159,"eighty":-1.093303,"marketCap":25199527},{"date":"2022-11-04","current":-1.034564,"twenty":-3.211281,"median":-1.781685,"eighty":-1.085971,"marketCap":26699002},{"date":"2022-11-11","current":-1.034564,"twenty":-3.19663,"median":-1.754132,"eighty":-1.064069,"marketCap":26699002},{"date":"2022-11-18","current":-2.138512,"twenty":-3.122051,"median":-1.781685,"eighty":-1.069544,"marketCap":26432011},{"date":"2022-11-25","current":-2.138296,"twenty":-3.034313,"median":-1.798653,"eighty":-1.076845,"marketCap":26429342},{"date":"2022-12-02","current":-2.268119,"twenty":-3.031897,"median":-1.811471,"eighty":-1.077913,"marketCap":28033952},{"date":"2022-12-09","current":-2.062476,"twenty":-2.987845,"median":-1.814802,"eighty":-1.085971,"marketCap":25492207},{"date":"2022-12-16","current":-1.706706,"twenty":-2.970163,"median":-1.831421,"eighty":-1.085971,"marketCap":21094881},{"date":"2022-12-23","current":-2.008905,"twenty":-2.954274,"median":-1.841415,"eighty":-1.085971,"marketCap":24830071},{"date":"2022-12-30","current":-1.97996,"twenty":-2.953963,"median":-1.87908,"eighty":-1.08618,"marketCap":24472305},{"date":"2023-01-06","current":-1.944102,"twenty":-2.952429,"median":-1.886392,"eighty":-1.090206,"marketCap":24029101},{"date":"2023-01-13","current":-2.157953,"twenty":-2.946433,"median":-1.900906,"eighty":-1.0942,"marketCap":26672302},{"date":"2023-01-20","current":-1.97348,"twenty":-2.935705,"median":-1.902631,"eighty":-1.095096,"marketCap":24392208},{"date":"2023-01-27","current":-1.983416,"twenty":-2.918789,"median":-1.907529,"eighty":-1.095096,"marketCap":24515023},{"date":"2023-02-03","current":-1.901116,"twenty":-2.907091,"median":-1.90622,"eighty":-1.098746,"marketCap":23497791},{"date":"2023-02-10","current":-1.761356,"twenty":-2.888081,"median":-1.904356,"eighty":-1.104222,"marketCap":21770366},{"date":"2023-02-17","current":-1.769997,"twenty":-2.860297,"median":-1.900906,"eighty":-1.107623,"marketCap":21877162},{"date":"2023-02-24","current":-1.620949,"twenty":-2.849692,"median":-1.893835,"eighty":-1.11285,"marketCap":20034931},{"date":"2023-03-03","current":-1.361087,"twenty":-2.82668,"median":-1.879083,"eighty":-1.113348,"marketCap":16823041},{"date":"2023-03-10","current":-23.153041,"twenty":-2.863221,"median":-1.882738,"eighty":-1.113348,"marketCap":14817946},{"date":"2023-03-17","current":-27.116173,"twenty":-2.939394,"median":-1.9009,"eighty":-1.115173,"marketCap":17354351},{"date":"2023-03-24","current":-25.864658,"twenty":-2.966985,"median":-1.901011,"eighty":-1.122474,"marketCap":16553381},{"date":"2023-03-31","current":-25.447527,"twenty":-3.122051,"median":-1.904912,"eighty":-1.122474,"marketCap":16286417},{"date":"2023-04-06","current":-25.447486,"twenty":-3.239037,"median":-1.907529,"eighty":-1.122474,"marketCap":16286391},{"date":"2023-04-14","current":-24.767495,"twenty":-3.3907,"median":-1.922393,"eighty":-1.1316,"marketCap":15851197},{"date":"2023-04-21","current":-25.038658,"twenty":-3.502605,"median":-1.933302,"eighty":-1.132397,"marketCap":16024741},{"date":"2023-04-28","current":-24.613142,"twenty":-3.637568,"median":-1.944102,"eighty":-1.139099,"marketCap":15752411},{"date":"2023-05-03","current":-24.821728,"twenty":-3.737688,"median":-1.944102,"eighty":-1.14255,"marketCap":15885906},{"date":"2023-05-12","current":-23.549353,"twenty":-3.962064,"median":-1.953389,"eighty":-1.150374,"marketCap":15071586},{"date":"2023-05-19","current":-0.906232,"twenty":-3.870018,"median":-1.944102,"eighty":-1.124299,"marketCap":12396346},{"date":"2023-05-26","current":-0.917357,"twenty":-3.849508,"median":-1.944102,"eighty":-1.113348,"marketCap":12548530},{"date":"2023-06-02","current":-0.907598,"twenty":-3.786842,"median":-1.922717,"eighty":-1.111024,"marketCap":12415035},{"date":"2023-06-09","current":-0.88808,"twenty":-3.758979,"median":-1.922285,"eighty":-1.095096,"marketCap":12148045},{"date":"2023-06-16","current":-0.829525,"twenty":-3.711367,"median":-1.907529,"eighty":-1.086128,"marketCap":11347075},{"date":"2023-06-23","current":-1.10766,"twenty":-3.661307,"median":-1.904634,"eighty":-1.085971,"marketCap":15151683},{"date":"2023-06-30","current":-1.034467,"twenty":-3.624407,"median":-1.901011,"eighty":-1.077059,"marketCap":14150471},{"date":"2023-07-07","current":-0.865634,"twenty":-3.61924,"median":-1.900903,"eighty":-1.058593,"marketCap":11841006},{"date":"2023-07-14","current":-0.941755,"twenty":-3.569747,"median":-1.886392,"eighty":-1.053985,"marketCap":12882267},{"date":"2023-07-21","current":-1.163287,"twenty":-3.502605,"median":-1.869469,"eighty":-1.049467,"marketCap":15912604},{"date":"2023-07-28","current":-1.204275,"twenty":-3.502605,"median":-1.836312,"eighty":-1.049467,"marketCap":16473283},{"date":"2023-08-04","current":-1.17207,"twenty":-3.403434,"median":-1.830588,"eighty":-1.050276,"marketCap":16032749},{"date":"2023-08-11","current":-1.050081,"twenty":-3.40315,"median":-1.814802,"eighty":-1.050276,"marketCap":14364062},{"date":"2023-08-18","current":-0.564163,"twenty":-3.3907,"median":-1.811471,"eighty":-1.049467,"marketCap":12787321},{"date":"2023-08-25","current":-0.552699,"twenty":-3.377958,"median":-1.798653,"eighty":-1.034564,"marketCap":12527472},{"date":"2023-09-01","current":-0.52253,"twenty":-3.322712,"median":-1.778373,"eighty":-1.033491,"marketCap":11843658},{"date":"2023-09-08","current":-0.513479,"twenty":-3.263311,"median":-1.770105,"eighty":-1.029914,"marketCap":11638514},{"date":"2023-09-15","current":-0.488137,"twenty":-3.240922,"median":-1.761356,"eighty":-1.013293,"marketCap":11064110},{"date":"2023-09-22","current":-0.517703,"twenty":-3.21713,"median":-1.75358,"eighty":-0.999188,"marketCap":11734248},{"date":"2023-09-29","current":-0.528564,"twenty":-3.210163,"median":-1.74386,"eighty":-0.98232,"marketCap":11980421},{"date":"2023-10-06","current":-0.515892,"twenty":-3.170308,"median":-1.731979,"eighty":-0.976461,"marketCap":11693219},{"date":"2023-10-13","current":-0.40125,"twenty":-3.078182,"median":-1.721224,"eighty":-0.974416,"marketCap":9094726},{"date":"2023-10-20","current":-0.276349,"twenty":-3.032863,"median":-1.709885,"eighty":-0.960388,"marketCap":6263736},{"date":"2023-10-27","current":-0.216614,"twenty":-3.031897,"median":-1.706706,"eighty":-0.958209,"marketCap":4909784},{"date":"2023-11-03","current":-0.295428,"twenty":-2.987845,"median":-1.685616,"eighty":-0.953765,"marketCap":6696180},{"date":"2023-11-10","current":-0.261799,"twenty":-2.970163,"median":-1.678137,"eighty":-0.940518,"marketCap":5933925},{"date":"2023-11-17","current":-0.217526,"twenty":-2.954274,"median":-1.668413,"eighty":-0.932386,"marketCap":5751810},{"date":"2023-11-24","current":-0.183663,"twenty":-2.953963,"median":-1.661099,"eighty":-0.922912,"marketCap":4856409},{"date":"2023-12-01","current":-0.192054,"twenty":-2.951944,"median":-1.645109,"eighty":-0.917162,"marketCap":5078286},{"date":"2023-12-08","current":-0.190837,"twenty":-2.944758,"median":-1.621837,"eighty":-0.911584,"marketCap":5046113},{"date":"2023-12-15","current":-0.175054,"twenty":-2.928328,"median":-1.61464,"eighty":-0.907362,"marketCap":4628765},{"date":"2023-12-22","current":-0.185385,"twenty":-2.91294,"median":-1.600191,"eighty":-0.900572,"marketCap":4901938},{"date":"2023-12-29","current":-0.163575,"twenty":-2.907091,"median":-1.589608,"eighty":-0.885033,"marketCap":4325239},{"date":"2024-01-05","current":-0.175054,"twenty":-2.902704,"median":-1.572154,"eighty":-0.867134,"marketCap":4628765},{"date":"2024-01-12","current":-0.131434,"twenty":-2.866146,"median":-1.516751,"eighty":-0.850799,"marketCap":3475368},{"date":"2024-01-19","current":-0.10389,"twenty":-2.854448,"median":-1.410777,"eighty":-0.829681,"marketCap":2747058},{"date":"2024-01-26","current":-0.084944,"twenty":-2.8442,"median":-1.402772,"eighty":-0.799999,"marketCap":2246089},{"date":"2024-02-02","current":-0.085053,"twenty":-2.779613,"median":-1.384283,"eighty":-0.620519,"marketCap":2248978},{"date":"2024-02-09","current":-0.070927,"twenty":-2.71595,"median":-1.37766,"eighty":-0.554991,"marketCap":1875445},{"date":"2024-02-16","current":-0.067492,"twenty":-2.693326,"median":-1.371037,"eighty":-0.547268,"marketCap":1784632},{"date":"2024-02-23","current":-0.096807,"twenty":-2.67312,"median":-1.360871,"eighty":-0.530494,"marketCap":2559764},{"date":"2024-03-01","current":-0.161236,"twenty":-2.649818,"median":-1.31805,"eighty":-0.527538,"marketCap":4263401},{"date":"2024-03-08","current":-0.229045,"twenty":-2.634657,"median":-1.292619,"eighty":-0.52253,"marketCap":6056401},{"date":"2024-03-15","current":-0.33683,"twenty":-2.626801,"median":-1.272589,"eighty":-0.518306,"marketCap":8906472},{"date":"2024-03-22","current":-0.316018,"twenty":-2.602928,"median":-1.245193,"eighty":-0.51541,"marketCap":6361766},{"date":"2024-03-28","current":-0.290737,"twenty":-2.582456,"median":-1.231946,"eighty":-0.513117,"marketCap":5852824},{"date":"2024-04-05","current":-0.429785,"twenty":-2.570757,"median":-1.221642,"eighty":-0.500804,"marketCap":8652002},{"date":"2024-04-12","current":-0.505629,"twenty":-2.563446,"median":-1.213732,"eighty":-0.500665,"marketCap":10178826},{"date":"2024-04-19","current":-0.422201,"twenty":-2.550285,"median":-1.201552,"eighty":-0.498515,"marketCap":8499319},{"date":"2024-04-26","current":-0.427257,"twenty":-2.525426,"median":-1.191588,"eighty":-0.460964,"marketCap":8601107},{"date":"2024-05-03","current":-0.452538,"twenty":-2.496179,"median":-1.178959,"eighty":-0.457095,"marketCap":9110049},{"date":"2024-05-10","current":-0.399447,"twenty":-2.475707,"median":-1.173046,"eighty":-0.438396,"marketCap":8041272},{"date":"2024-05-17","current":-0.240254,"twenty":-2.462546,"median":-1.171094,"eighty":-0.430796,"marketCap":5547460},{"date":"2024-05-24","current":-0.233641,"twenty":-2.44646,"median":-1.163287,"eighty":-0.420684,"marketCap":5394777},{"date":"2024-05-31","current":-0.22262,"twenty":-2.440611,"median":-1.153528,"eighty":-0.404698,"marketCap":5140307},{"date":"2024-06-07","current":-0.224825,"twenty":-2.431837,"median":-1.150713,"eighty":-0.39338,"marketCap":5191201},{"date":"2024-06-14","current":-0.218212,"twenty":-2.420138,"median":-1.143223,"eighty":-0.377958,"marketCap":5038518},{"date":"2024-06-21","current":-0.227029,"twenty":-2.414289,"median":-1.132815,"eighty":-0.32637,"marketCap":5242095},{"date":"2024-06-28","current":-0.198375,"twenty":-2.404053,"median":-1.132098,"eighty":-0.322086,"marketCap":4580476},{"date":"2024-07-05","current":-0.182946,"twenty":-2.368957,"median":-1.122474,"eighty":-0.316018,"marketCap":4224212},{"date":"2024-07-12","current":-0.242458,"twenty":-2.354334,"median":-1.113348,"eighty":-0.298321,"marketCap":5598354},{"date":"2024-07-15","current":-0.232539,"twenty":-2.349947,"median":-1.113348,"eighty":-0.298028,"marketCap":5369330},{"date":"2024-08-02","current":-0.249115,"twenty":-2.34556,"median":-1.113348,"eighty":-0.296658,"marketCap":5752054},{"date":"2024-08-09","current":-0.27552,"twenty":-2.314851,"median":-1.110193,"eighty":-0.291016,"marketCap":6361766},{"date":"2024-08-16","current":-0.436989,"twenty":-2.281143,"median":-1.104222,"eighty":-0.282675,"marketCap":5903719},{"date":"2024-08-23","current":-0.512909,"twenty":-2.269285,"median":-1.095096,"eighty":-0.285652,"marketCap":6929397},{"date":"2024-08-30","current":-0.453411,"twenty":-2.268119,"median":-1.086232,"eighty":-0.289542,"marketCap":6125587},{"date":"2024-09-06","current":-0.459566,"twenty":-2.268119,"median":-1.085971,"eighty":-0.290876,"marketCap":6208740},{"date":"2024-09-13","current":-0.504702,"twenty":-2.268119,"median":-1.077379,"eighty":-0.291915,"marketCap":6818527},{"date":"2024-09-20","current":-0.525219,"twenty":-2.26489,"median":-1.063156,"eighty":-0.294158,"marketCap":7095703},{"date":"2024-09-27","current":-0.517012,"twenty":-2.2515,"median":-1.058593,"eighty":-0.295501,"marketCap":6984832},{"date":"2024-10-04","current":-0.475979,"twenty":-2.248992,"median":-1.053985,"eighty":-0.296225,"marketCap":6430480},{"date":"2024-10-11","current":-0.289691,"twenty":-2.243222,"median":-1.050178,"eighty":-0.296225,"marketCap":3913723},{"date":"2024-10-18","current":-0.308156,"twenty":-2.229013,"median":-1.049467,"eighty":-0.298028,"marketCap":4163182},{"date":"2024-10-25","current":-0.398017,"twenty":-2.224479,"median":-1.040342,"eighty":-0.298321,"marketCap":5377212},{"date":"2024-10-31","current":-0.383204,"twenty":-2.222725,"median":-1.037453,"eighty":-0.298321,"marketCap":5177091},{"date":"2024-11-08","current":-0.361088,"twenty":-2.215414,"median":-1.034564,"eighty":-0.303378,"marketCap":4878295},{"date":"2024-11-15","current":-0.304447,"twenty":-2.215414,"median":-1.032353,"eighty":-0.304447,"marketCap":3908180},{"date":"2024-11-22","current":-0.327766,"twenty":-2.208102,"median":-1.031216,"eighty":-0.304447,"marketCap":4207530},{"date":"2024-11-29","current":-0.543296,"twenty":-2.204273,"median":-1.02209,"eighty":-0.307414,"marketCap":6974289},{"date":"2024-12-06","current":-0.609699,"twenty":-2.203316,"median":-1.01317,"eighty":-0.311077,"marketCap":7826703},{"date":"2024-12-13","current":-0.639882,"twenty":-2.186035,"median":-1.003838,"eighty":-0.313349,"marketCap":8214163},{"date":"2024-12-20","current":-0.615735,"twenty":-2.181715,"median":-0.990509,"eighty":-0.315561,"marketCap":7904195},{"date":"2024-12-27","current":-0.645918,"twenty":-2.18,"median":-0.984212,"eighty":-0.316224,"marketCap":8291655},{"date":"2025-01-03","current":-0.657992,"twenty":-2.175931,"median":-0.97836,"eighty":-0.316605,"marketCap":8446639},{"date":"2025-01-10","current":-0.712321,"twenty":-2.170082,"median":-0.976461,"eighty":-0.317285,"marketCap":9144068},{"date":"2025-01-17","current":-0.645918,"twenty":-2.164233,"median":-0.975912,"eighty":-0.318547,"marketCap":8291655},{"date":"2025-01-24","current":-0.651955,"twenty":-2.164233,"median":-0.973635,"eighty":-0.318547,"marketCap":8369147},{"date":"2025-01-31","current":-0.639882,"twenty":-2.160113,"median":-0.961163,"eighty":-0.321075,"marketCap":8214163},{"date":"2025-02-07","current":-0.700248,"twenty":-2.160113,"median":-0.958209,"eighty":-0.326131,"marketCap":8989084},{"date":"2025-02-14","current":-0.706285,"twenty":-2.159897,"median":-0.956813,"eighty":-0.32643,"marketCap":9066576},{"date":"2025-02-21","current":-0.694211,"twenty":-2.158342,"median":-0.950453,"eighty":-0.327499,"marketCap":8911592},{"date":"2025-02-28","current":-0.588993,"twenty":-2.157127,"median":-0.941755,"eighty":-0.328163,"marketCap":7560905},{"date":"2025-03-07","current":-0.539915,"twenty":-2.156921,"median":-0.936875,"eighty":-0.331147,"marketCap":6930894},{"date":"2025-03-14","current":-0.567442,"twenty":-2.149021,"median":-0.932386,"eighty":-0.33522,"marketCap":7284258},{"date":"2025-03-21","current":-0.621772,"twenty":-2.144367,"median":-0.925242,"eighty":-0.336386,"marketCap":7981687},{"date":"2025-03-28","current":-0.423584,"twenty":-2.142578,"median":-0.921706,"eighty":-0.336726,"marketCap":7522432},{"date":"2025-04-04","current":-0.393453,"twenty":-2.139269,"median":-0.916869,"eighty":-0.336822,"marketCap":6987334},{"date":"2025-04-11","current":-0.404246,"twenty":-2.138339,"median":-0.91258,"eighty":-0.336822,"marketCap":7179010},{"date":"2025-04-17","current":-0.417238,"twenty":-2.138166,"median":-0.907598,"eighty":-0.339174,"marketCap":7409733},{"date":"2025-04-25","current":-0.41424,"twenty":-2.125638,"median":-0.9075,"eighty":-0.3414,"marketCap":7356489},{"date":"2025-05-02","current":-0.344834,"twenty":-2.110345,"median":-0.906232,"eighty":-0.343542,"marketCap":6123909},{"date":"2025-05-09","current":-0.363472,"twenty":-2.099513,"median":-0.900279,"eighty":-0.34477,"marketCap":6454898},{"date":"2025-05-16","current":-0.349755,"twenty":-2.088996,"median":-0.883001,"eighty":-0.34477,"marketCap":6211299},{"date":"2025-05-23","current":-0.514188,"twenty":-2.084725,"median":-0.866384,"eighty":-0.346273,"marketCap":5926011},{"date":"2025-05-30","current":-0.469837,"twenty":-2.081432,"median":-0.858803,"eighty":-0.348052,"marketCap":5414873},{"date":"2025-06-06","current":-0.491366,"twenty":-2.073569,"median":-0.842312,"eighty":-0.349471,"marketCap":5662995},{"date":"2025-06-13","current":-0.532757,"twenty":-2.0665,"median":-0.829622,"eighty":-0.349765,"marketCap":6140028},{"date":"2025-06-20","current":-0.532675,"twenty":-2.060618,"median":-0.825469,"eighty":-0.349781,"marketCap":6139083},{"date":"2025-06-27","current":-0.512185,"twenty":-2.052928,"median":-0.799785,"eighty":-0.349951,"marketCap":5902928},{"date":"2025-07-03","current":-0.573739,"twenty":-2.05189,"median":-0.78639,"eighty":-0.35063,"marketCap":6612337},{"date":"2025-07-11","current":-0.695043,"twenty":-2.046923,"median":-0.71534,"eighty":-0.351281,"marketCap":8010375},{"date":"2025-07-18","current":-0.697502,"twenty":-2.041307,"median":-0.706285,"eighty":-0.356276,"marketCap":8038713},{"date":"2025-07-25","current":-0.905687,"twenty":-2.039935,"median":-0.712329,"eighty":-0.356574,"marketCap":10438047},{"date":"2025-08-01","current":-0.885197,"twenty":-2.030507,"median":-0.718358,"eighty":-0.359175,"marketCap":10201892},{"date":"2025-08-08","current":-0.835717,"twenty":-2.008905,"median":-0.762437,"eighty":-0.359446,"marketCap":9631638},{"date":"2025-08-15","current":-0.621125,"twenty":-2.003377,"median":-0.78639,"eighty":-0.359774,"marketCap":10305714},{"date":"2025-08-22","current":-0.563064,"twenty":-1.997241,"median":-0.720716,"eighty":-0.359774,"marketCap":9342354},{"date":"2025-08-29","current":-0.547503,"twenty":-1.992921,"median":-0.712337,"eighty":-0.361088,"marketCap":9084178},{"date":"2025-09-05","current":-0.539402,"twenty":-1.992575,"median":-0.712321,"eighty":-0.362007,"marketCap":8949755},{"date":"2025-09-12","current":-0.535608,"twenty":-1.991884,"median":-0.704879,"eighty":-0.363225,"marketCap":8886812},{"date":"2025-09-19","current":-0.555219,"twenty":-1.98819,"median":-0.697502,"eighty":-0.364471,"marketCap":9212199},{"date":"2025-09-26","current":-0.617332,"twenty":-1.984194,"median":-0.694211,"eighty":-0.365097,"marketCap":10242771},{"date":"2025-10-03","current":-0.668707,"twenty":-1.980651,"median":-0.694211,"eighty":-0.365292,"marketCap":11095179},{"date":"2025-10-10","current":-0.668642,"twenty":-1.974776,"median":-0.691307,"eighty":-0.368878,"marketCap":11094112},{"date":"2025-10-17","current":-0.636557,"twenty":-1.962302,"median":-0.685372,"eighty":-0.371766,"marketCap":10561757},{"date":"2025-10-24","current":-0.726575,"twenty":-1.949718,"median":-0.682138,"eighty":-0.372384,"marketCap":12055339},{"date":"2025-10-31","current":-0.687996,"twenty":-1.944736,"median":-0.682138,"eighty":-0.372708,"marketCap":11415232},{"date":"2025-11-07","current":-0.745865,"twenty":-1.944102,"median":-0.683755,"eighty":-0.374768,"marketCap":12375392},{"date":"2025-11-14","current":-0.572323,"twenty":-1.944102,"median":-0.682138,"eighty":-0.377419,"marketCap":9495980},{"date":"2025-11-21","current":-0.499555,"twenty":-1.944102,"median":-0.681566,"eighty":-0.382155,"marketCap":8778176},{"date":"2025-11-28","current":-0.541516,"twenty":-1.943972,"median":-0.678834,"eighty":-0.385149,"marketCap":9515515},{"date":"2025-12-05","current":-0.549139,"twenty":-1.931185,"median":-0.676102,"eighty":-0.386667,"marketCap":9649470},{"date":"2025-12-12","current":-0.538864,"twenty":-1.922587,"median":-0.670065,"eighty":-0.388327,"marketCap":9468921},{"date":"2025-12-19","current":-0.504129,"twenty":-1.922371,"median":-0.670065,"eighty":-0.389335,"marketCap":8858549},{"date":"2025-12-26","current":-0.477282,"twenty":-1.921507,"median":-0.670065,"eighty":-0.390001,"marketCap":8386792},{"date":"2026-01-02","current":-0.377848,"twenty":-1.917779,"median":-0.668707,"eighty":-0.389668,"marketCap":6639544},{"date":"2026-01-09","current":-0.545493,"twenty":-1.907529,"median":-0.668513,"eighty":-0.391173,"marketCap":9585404},{"date":"2026-01-16","current":-0.553514,"twenty":-1.907006,"median":-0.664028,"eighty":-0.392181,"marketCap":9726349},{"date":"2026-01-23","current":-0.662891,"twenty":-1.904912,"median":-0.664028,"eighty":-0.393453,"marketCap":11648323},{"date":"2026-01-30","current":-0.653611,"twenty":-1.904356,"median":-0.662584,"eighty":-0.393914,"marketCap":11485246},{"date":"2026-02-06","current":-0.555436,"twenty":-1.901116,"median":-0.661565,"eighty":-0.395966,"marketCap":9760129},{"date":"2026-02-13","current":-0.523684,"twenty":-1.900906,"median":-0.657992,"eighty":-0.397301,"marketCap":9202175},{"date":"2026-02-17","current":-0.516193,"twenty":-1.900906,"median":-0.657992,"eighty":-0.397444,"marketCap":9070549}],"updateTime":1771432604072},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BFRI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612731450","title":"Biofrontera Locks Phase 1 PK Study Database for Ameluz in Actinic Keratoses Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2612731450","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612731450?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:15","pubTimestamp":1771337721,"startTime":"0","endTime":"0","summary":"Biofrontera Inc. announced the completion and database lock of its Phase 1 pharmacokinetics  study evaluating Ameluz topical gel for the treatment of mild to moderate actinic keratoses  on the neck, trunk, and extremities. The PK data, together with previously announced positive Phase 3 efficacy results, are intended to support a supplemental New Drug Application for label expansion in the U.S., with submission expected in the third quarter of 2026. Study results have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biofrontera Inc. published the original content used to generate this news brief via GlobeNewswire  on February 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL7YlD7C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BFRI","SG9999014021.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","NDAQ","BK4112","BK4588","BK4585","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014005.SGD","BK4007"],"gpt_icon":0},{"id":"2612507894","title":"Biofrontera Inc - Supplemental Nda Submission for Extremities, Neck and Trunk Indication Expected in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612507894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612507894?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:15","pubTimestamp":1771337700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUA2NM73Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BFRIW","BFRI","BK4007"],"gpt_icon":0},{"id":"2612450266","title":"Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Keratoses on Trunk and Extremities","url":"https://stock-news.laohu8.com/highlight/detail?id=2612450266","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612450266?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:15","pubTimestamp":1771337700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUA2NM73Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BFRI","BFRIW"],"gpt_icon":0},{"id":"2611172112","title":"Biofrontera Raises 2025 EBITDA Outlook While Keeping Revenue Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2611172112","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611172112?lang=en_us&edition=fundamental","pubTime":"2026-02-14 20:27","pubTimestamp":1771072079,"startTime":"0","endTime":"0","summary":"The latest update is out from Biofrontera ( ($DE:B8FK) ). Biofrontera AG has raised its EBITDA forecast for fiscal 2025, now expecting between EUR ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biofrontera-raises-2025-ebitda-outlook-while-keeping-revenue-target?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biofrontera-raises-2025-ebitda-outlook-while-keeping-revenue-target?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BFRI"],"gpt_icon":0},{"id":"2610995532","title":"FDA Accepts Biofrontera sNDA Filing for Ameluz PDT in Superficial Basal Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2610995532","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610995532?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819316,"startTime":"0","endTime":"0","summary":"Biofrontera Inc. announced that the U.S. Food and Drug Administration  has accepted the filing of the company’s supplemental New Drug Application  for Ameluz  topical gel in combination with the RhodoLED red-light lamp series for the treatment of superficial basal cell carcinoma . The FDA identified no filing deficiencies and assigned a Prescription Drug User Fee Act  target action date of September 28, 2026. If approved, Ameluz would become the first and only photodynamic therapy  photosensitizer indicated for the treatment of sBCC in the United States. The new indication would represent an expansion of Ameluz's clinical use beyond its current FDA approval for the treatment of actinic keratosis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL315Fcp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014013.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","IE00BKPKM429.USD","BFRI","NDAQ","LU0314104364.USD","SG9999014039.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014005.SGD","BK4585","BK4007","BK4112"],"gpt_icon":0},{"id":"2610795536","title":"Biofrontera Inc - FDA Sets Pdufa Date for September 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610795536","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610795536?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUA1M5076:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BFRIW","BK4007","BFRI"],"gpt_icon":0},{"id":"2610362955","title":"Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® Pdt in Superficial Basal Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2610362955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610362955?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUA1M5076:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BFRI","BFRIW"],"gpt_icon":0},{"id":"2610065916","title":"BRIEF-Biofrontera Announces Positive Results In Phase 3 Study Of Ameluz® Pdt","url":"https://stock-news.laohu8.com/highlight/detail?id=2610065916","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610065916?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:41","pubTimestamp":1770648094,"startTime":"0","endTime":"0","summary":"BRIEF-Biofrontera Announces Positive Results In Phase 3 Study Of Ameluz Pdt Feb 9 (Reuters) - Biofrontera Inc BFRI.O:BIOFRONTERA ANNOUNCES POSITIVE RESULTS IN PHASE 3 STUDY OF AMELUZ PDT FOR ACTINIC K","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABHPDDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI","BFRIW","BK4007"],"gpt_icon":0},{"id":"2610165690","title":"Biofrontera Reports Positive Phase 3 Results for Ameluz PDT in Treating Actinic Keratoses Beyond Face and Scalp","url":"https://stock-news.laohu8.com/highlight/detail?id=2610165690","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610165690?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:15","pubTimestamp":1770646522,"startTime":"0","endTime":"0","summary":"Biofrontera Inc. has announced positive and statistically significant top-line results from its Phase 3 clinical trial evaluating Ameluz photodynamic therapy  with the red-light LED  platform for the treatment of mild to moderate actinic keratoses  on the extremities, neck, and trunk. The multicenter, randomized, double-blind, vehicle-controlled study enrolled 172 patients and met its primary endpoint, demonstrating highly statistically significant superiority for Ameluz compared to vehicle gel . Based on these results, Biofrontera plans to submit a supplemental New Drug Application  to the U.S. Food and Drug Administration in the third quarter of 2026. The results have already been announced and presented by the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL5TjYGh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","BFRI","BK4588","SG9999014039.USD","BK4112","NDAQ","BK4007","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2610971656","title":"Biofrontera Inc - to Submit Snda to FDA in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610971656","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610971656?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:15","pubTimestamp":1770646500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABHPDDP:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BFRI","BK4007","BFRIW"],"gpt_icon":0},{"id":"2610656979","title":"Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® Pdt for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2610656979","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610656979?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:15","pubTimestamp":1770646500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABHPDDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BFRI","BFRIW","BK4007"],"gpt_icon":0},{"id":"2610656975","title":"Biofrontera Inc - Ameluz Pdt Achieves 45.6% Clearance Rate in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2610656975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610656975?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:15","pubTimestamp":1770646500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABHPDDP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BFRIW","BFRI","BK4007"],"gpt_icon":0},{"id":"2610569766","title":"Biofrontera Inc - Primary Endpoint Achieved With Complete Clearance Rate of Ak Lesions","url":"https://stock-news.laohu8.com/highlight/detail?id=2610569766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610569766?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:15","pubTimestamp":1770646500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABHPDDP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BFRIW","BFRI"],"gpt_icon":0},{"id":"2610465697","title":"Biofrontera Inc - Ak Lesion Clearance 73.1% in Fas and 80.3% in PPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2610465697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610465697?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:15","pubTimestamp":1770646500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUABHPDDP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BFRIW","BFRI"],"gpt_icon":0},{"id":"2605403879","title":"There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2605403879","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605403879?lang=en_us&edition=fundamental","pubTime":"2026-01-23 18:32","pubTimestamp":1769164328,"startTime":"0","endTime":"0","summary":"Those holding Biofrontera Inc. ( NASDAQ:BFRI ) shares would be relieved that the share price has rebounded 42% in the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bfri/biofrontera/news/theres-no-escaping-biofrontera-incs-nasdaqbfri-muted-revenue","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bfri/biofrontera/news/theres-no-escaping-biofrontera-incs-nasdaqbfri-muted-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BFRI",".IXIC"],"gpt_icon":0},{"id":"2603825056","title":"Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues Between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2603825056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603825056?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:31","pubTimestamp":1768311105,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE05H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BFRI","BK4007"],"gpt_icon":0},{"id":"2603825416","title":"Biofrontera Inc. Projects 2025 Revenue Growth of Up to 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603825416","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603825416?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:31","pubTimestamp":1768311098,"startTime":"0","endTime":"0","summary":"Biofrontera Inc. announced preliminary unaudited revenue results for the fourth quarter ended December 31, 2025, expecting revenues between $17.0 million and $17.5 million. This represents the highest quarterly revenue in the company’s history and a year-over-year growth of approximately 35% to 39%, driven by strong sales execution of Ameluz. For the full year 2025, Biofrontera anticipates revenues in the range of $41.5 million to $42.0 million, reflecting double-digit growth of approximately 11% to 13% compared to the previous year. The company attributes these results to continued growth of its Ameluz photodynamic therapy product and a pricing adjustment introduced in December.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biofronte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLbCbbtJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BFRI","IE00BKPKM429.USD","BK4007","BK4588","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","SG9999014021.USD","SG9999014005.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2601398253","title":"BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2601398253","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601398253?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:40","pubTimestamp":1767883218,"startTime":"0","endTime":"0","summary":"BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory MilestonesJan 8 (Reuters) - Biofrontera Inc BFRI.O:BIOFRONTERA INC. ANNOUNCES DATA BASE LOCKS FO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA54FNPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRIW","BK4007","BFRI"],"gpt_icon":0},{"id":"2601367875","title":"Biofrontera Inc. Locks Databases for Key Ameluz PDT Clinical Trials in Actinic Keratosis and Acne Vulgaris","url":"https://stock-news.laohu8.com/highlight/detail?id=2601367875","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601367875?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:45","pubTimestamp":1767879913,"startTime":"0","endTime":"0","summary":"Biofrontera Inc. has announced the successful database lock for two clinical studies evaluating Ameluz photodynamic therapy  for actinic keratosis  and acne vulgaris. The locked databases pertain to a Phase 3 study for AK on the extremities, neck, and trunk, and a Phase 2 study for moderate to severe acne vulgaris. Data from both studies are expected to be available in February 2026. The results of the Phase 3 AK study will support a planned supplemental New Drug Application  to the U.S. FDA in summer 2026 to expand the approved use of Ameluz PDT. Results from the acne vulgaris study are expected to be presented to the FDA in early Q3 2026 to support a future Phase 3 program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biofrontera I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL1CLr2X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014005.SGD","BK4588","BFRI","IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","IE00BKPKM429.USD","BK4007","BK4585","BK4112"],"gpt_icon":0},{"id":"2601678293","title":"Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2601678293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601678293?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:45","pubTimestamp":1767879900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA54FNPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BFRI","BK4007","BFRIW"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":76,"code":"91000000","status":"200"}]}}